Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


COMMENT: 'Bad Pharma' gets a scolding from Goldacre

This article was originally published in Scrip

Executive Summary

Criticizing the pharmaceutical industry, I've recently discovered, is a little like questioning a cult: there are outlandish smears, lurid denunciations, and implausible outright denials. People within the community award themselves a point for this behavior, while outsiders look on in amazement. I’d like to speak with those of you who are able to step outside of this game.

You may also be interested in...

It's time for pharma to change its ways on transparency

Transparency is an unstoppable tide and the industry should embrace it rather than fight against it, says Ben Goldacre.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts